Hagens Berman Expands Legal Actions Against Gemini, Kyndryl, uniQure, and ODDITY Tech
Key Facts
Law firm Hagens Berman has expanded its legal actions and investigations against several firms, including Gemini, Kyndryl, uniQure, and ODDITY Tech, following significant stock price declines. The litigation involves a 75% drop in Gemini's stock, cash flow reporting issues at Kyndryl, and FDA-related investigations concerning uniQure. Regarding ODDITY Tech (ODD), the lawsuit alleges misleading disclosures about advertising efficiency after an ad partner's algorithm change spiked operational costs. The legal notice specifically targets institutional investors, including pension funds, asset managers, and fiduciaries holding positions in the company. Furthermore, the class action period for affected investors has been officially defined as February 26, 2025, through February 24, 2026. These developments underscore the increasing legal pressure on firms to maintain transparency in their financial reporting and operational disclosures.